Drugs / Helium/Oxygen
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01155310 | May 2010 → Oct 2013 | chronic obstructive pulmonary disease | Air Liquide | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Helium/Oxygen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01155310 ↗ |
| Known as | He/O2 | “The primary objective of the study is to evaluate the efficacy of Helium/Oxygen (He/O2) 78%/22% compared to a conventional Air/O2 mixture” NCT01155310 ↗ |
| Known as | heliox | “During noninvasive ventilation (NIV) for chronic obstructive pulmonary disease (COPD) exacerbations, helium/oxygen (heliox) reduces the work of breathing and hypercapnia more...” PMID 27736154 ↗ Apr 2017 |
| Route | Inhaled | “During NIV sessions, gas mixtures will be administered using a ventilator suitable for NIV with either He/O2 or Air/O2 and a NIV facemask.” NCT01155310 ↗ |